Literature DB >> 7427206

Acute renal failure and myopathy after treatment with aminocaproic acid.

C K Biswas, D A Milligan, S D Agte, D H Kenward, P J Tilley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7427206      PMCID： PMC1713609          DOI： 10.1136/bmj.281.6233.115-a

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  5 in total

1.  EPSILON AMINO CAPROIC ACID THERAPY AS A CAUSE OF INTRARENAL OBSTRUCTION IN HAEMATURIA OF HAEMOPHILIACS.

Authors:  S N STARK; J G WHITE; R L LANGE; W KRIVIT
Journal:  Scand J Haematol       Date:  1965

2.  Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. A double-blind study.

Authors:  M M Frank; J S Sergent; M A Kane; D W Alling
Journal:  N Engl J Med       Date:  1972-04-13       Impact factor: 91.245

3.  Glomerular capillary thrombosis and acute renal failure after epsilon-amino caproic acid therapy.

Authors:  C Charytan; D Purtilo
Journal:  N Engl J Med       Date:  1969-05-15       Impact factor: 91.245

4.  Epsilon aminocaproic acid (EACA) myopathy.

Authors:  R J Lane; N J McLelland; A M Martin; F L Mastaglia
Journal:  Postgrad Med J       Date:  1979       Impact factor: 2.401

5.  Drug-induced myopathies in man.

Authors:  R J Lane; F L Mastaglia
Journal:  Lancet       Date:  1978-09-09       Impact factor: 79.321
  5 in total
  5 in total

Review 1.  Antifibrinolytic agents in subarachnoid haemorrhage.

Authors:  K W Lindsay
Journal:  J Neurol       Date:  1987-01       Impact factor: 4.849

Review 2.  Clinical application of inhibitors of fibrinolysis.

Authors:  M Verstraete
Journal:  Drugs       Date:  1985-03       Impact factor: 9.546

Review 3.  Adverse effects of drugs on muscle.

Authors:  F L Mastaglia
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

Review 4.  Antifibrinolytic therapy to prevent early rebleeding after subarachnoid hemorrhage.

Authors:  Mark Chwajol; Robert M Starke; Grace H Kim; Stephan A Mayer; E Sander Connolly
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

5.  Effect of hyperbaric oxygen therapy on essential haematuria.

Authors:  T Nakada; I Sasagawa; H Koike; H Furuta; T Katayama; K Ota; M Chikenji; T Matsushita; H Saito
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.